How to Get Sildenafil (Generic) in Delaware

Delaware Prescribing Rules for Sildenafil

Any Delaware-licensed physician (MD or DO), nurse practitioner with APRN-Rx authority, or physician assistant may prescribe sildenafil. The state does not classify sildenafil as a controlled substance, so no DEA registration beyond the standard state license is necessary for prescribing. Delaware Board of Medical Licensure guidelines require a valid provider-patient relationship, which can be established via telehealth under Delaware Code Title 24, Chapter 17 1.

The 1998 landmark trial by Goldstein et al. (N=532) established sildenafil's efficacy, with 69% of intercourse attempts succeeding on sildenafil versus 22% on placebo 1. That trial led the FDA to approve sildenafil citrate on March 27, 1998, as the first oral PDE5 inhibitor for erectile dysfunction 2. Generic versions became available in December 2017 after Pfizer's patent expiration, and the FDA Orange Book now lists more than 15 approved ANDA holders 3.

Delaware prescribers should document the clinical indication (erectile dysfunction vs. pulmonary arterial hypertension) because dosing schedules differ significantly. The AUA Guideline on Erectile Dysfunction (2018, amended 2023) recommends PDE5 inhibitors as first-line pharmacotherapy for ED in men without contraindications 4.

Telehealth Access in Delaware

Delaware is one of the states with broad telehealth prescribing authority for non-controlled medications. A provider licensed in Delaware can evaluate a patient via synchronous video or audio-visual visit and prescribe sildenafil the same day. No prior in-person examination is mandated for non-controlled prescriptions under Delaware's telehealth parity law.

This matters. A 2021 cross-sectional analysis published in JAMA Network Open found that telehealth visits for ED increased by 565% between January 2019 and June 2021, with sildenafil and tadalafil representing the majority of prescriptions written 5. For Delaware residents in Sussex or Kent counties, where urologist access can involve drives exceeding 45 minutes, telehealth removes a genuine barrier. HealthRX operates a telehealth platform licensed in Delaware that connects patients with prescribers who can evaluate, prescribe, and route sildenafil to a patient's preferred pharmacy.

The clinical workflow typically follows this sequence: a patient completes an intake questionnaire covering cardiovascular history, current medications (with specific screening for nitrates and alpha-blockers), and symptom severity using the IIEF-5 (SHIM) score 6. A licensed provider reviews the intake, conducts a synchronous visit, and writes the prescription electronically. Most patients receive their prescription within 24 hours.

Required Labs and Medical Evaluation

Delaware does not mandate specific laboratory tests before sildenafil prescribing, but clinical guidelines inform what a responsible prescriber should order. The Endocrine Society Clinical Practice Guideline (2018) recommends checking a morning total testosterone level in men presenting with ED, because 10 to 20% of men with ED have concurrent hypogonadism 7. Testosterone replacement alone may resolve ED in hypogonadal men, or it may augment PDE5 inhibitor response in others.

A basic metabolic panel and lipid panel are clinically appropriate for men over 40, given that ED frequently presents 3 to 5 years before a cardiovascular event. The Princeton III Consensus (2012) stratified ED patients into low, intermediate, and high cardiovascular risk categories 8. Low-risk patients can begin PDE5 inhibitors without further cardiac workup. Intermediate-risk patients need exercise stress testing before starting sildenafil. High-risk patients should be referred to cardiology before any ED pharmacotherapy.

A hemoglobin A1c is reasonable for men who have not been screened for diabetes, since diabetes is present in roughly 35 to 50% of men with ED. The ADA Standards of Care (2024) note that PDE5 inhibitors remain first-line for diabetic men with ED, though response rates may be lower (approximately 56% vs. 72% in non-diabetic men) 9.

Not every patient needs labs. A 28-year-old with situational ED but no cardiovascular risk factors, stable weight, and no medication history can reasonably be prescribed sildenafil after a thorough history and review of systems.

Dosing and Administration

Sildenafil for ED is taken on-demand, 30 to 60 minutes before anticipated sexual activity. The recommended starting dose is 50 mg for most men. Based on efficacy and tolerability, the dose can be adjusted to 25 mg or increased to 100 mg 2. Maximum recommended frequency is once per 24-hour period.

There is a clinical nuance with the 20 mg tablet. The FDA-approved 20 mg strength (Revatio) is labeled for pulmonary arterial hypertension (PAH) at 20 mg three times daily 10. Prescribers sometimes write sildenafil 20 mg with instructions to take multiple tablets for ED. This is off-label but extremely common because the 20 mg generic tablets are often cheaper per milligram. A patient taking five 20 mg tablets (100 mg total) pays substantially less at many pharmacies than filling a single 100 mg tablet prescription.

High-fat meals delay sildenafil absorption by approximately 60 minutes and reduce peak plasma concentration (Cmax) by 29%, according to the FDA label 2. Advise patients to take sildenafil on an empty stomach or after a light meal for more predictable onset.

A 2002 meta-analysis in the BMJ (N=6,659 across 10 RCTs) confirmed that sildenafil produced successful intercourse in 57% of attempts versus 21% with placebo, with no significant difference in efficacy between the 50 mg and 100 mg doses for the average patient 11.

Drug Interactions and Contraindications

Sildenafil is absolutely contraindicated with nitrates. Concomitant use of sildenafil and any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite) can produce severe, potentially fatal hypotension 2. The ACC/AHA guidelines specify a minimum 24-hour washout period after sildenafil before administering nitrates 12.

Alpha-blockers (tamsulosin, doxazosin, terazosin) interact with sildenafil. The FDA label recommends starting sildenafil at 25 mg when co-prescribed with an alpha-blocker, and patients should be stable on their alpha-blocker regimen before adding sildenafil 2.

Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) increase sildenafil plasma levels two- to eleven-fold. When ritonavir is co-administered, the sildenafil AUC increases by 1,100% 2. Dose reduction to 25 mg with extended dosing intervals is mandatory.

Grapefruit juice is a moderate CYP3A4 inhibitor and can modestly increase sildenafil levels. The clinical significance is small, but patients should be aware.

Pharmacy Options in Delaware

Delaware has approximately 200 retail pharmacies across its three counties (New Castle, Kent, and Sussex). Every major chain pharmacy stocks generic sildenafil: CVS, Walgreens, Rite Aid, and Walmart all carry it. Independent pharmacies typically stock the 20 mg and 100 mg strengths.

For pricing, GoodRx data (accessed May 2026) shows that generic sildenafil 100 mg tablets cost between $0.40 and $3.50 per tablet at Delaware pharmacies, depending on quantity and coupon availability. The 20 mg strength is often cheaper per tablet (approximately $0.30 to $1.00) because of PAH pricing structures.

Licensed 503A compounding pharmacies in Delaware can prepare custom sildenafil formulations. These include sublingual troches, oral suspensions, and combination products (such as sildenafil/oxytocin troches). All 503A pharmacies must comply with USP <795> standards and Delaware Board of Pharmacy regulations. Compounded sildenafil requires a patient-specific prescription 13.

One key distinction: 503A pharmacies compound for individual patients and can dispense within Delaware. 503B outsourcing facilities operate under FDA registration and can distribute across state lines without patient-specific prescriptions. Both pathways are legal, but the prescriber must specify whether the prescription is for a 503A compound or a commercially available generic 13.

Delaware Medicaid and Insurance Coverage

Delaware Medicaid covers generic sildenafil for erectile dysfunction, but prior authorization is required. The PA process typically requires documentation of the following: confirmed ED diagnosis (ICD-10 code N52.xx), trial and failure or contraindication to non-pharmacologic therapies, absence of nitrate use, and documentation that the condition is not secondary to an excluded etiology.

Delaware Medicaid limits coverage to a defined quantity per month (commonly 6 to 8 tablets per 30-day period). The prescriber's office submits the PA electronically through the state's pharmacy benefit manager. Turnaround time is typically 24 to 72 hours. Denials can be appealed; the prescriber should include the AUA guideline citation supporting PDE5 inhibitors as first-line therapy 4.

For commercial insurance, coverage varies by plan. Many employer-sponsored plans exclude ED medications entirely, while others cover them with a $30 to $75 copay tier. Given that generic sildenafil is now available for as little as $0.30 per tablet at cash-pay pricing, some patients find it cheaper to bypass insurance altogether.

Medicare Part D covers sildenafil for PAH (as Revatio 20 mg) but generally does not cover sildenafil prescribed for ED. This is a CMS-level exclusion under the Social Security Act Section 1860D-2(e)(2)(A) 14.

Transferring a Prescription to Delaware

If you hold a valid sildenafil prescription from another state, any Delaware pharmacy can accept a transfer. The originating pharmacy communicates the prescription details (drug, dose, quantity, refills remaining, prescriber information) to the receiving Delaware pharmacy, either by phone or through an electronic transfer system. The Delaware Board of Pharmacy permits incoming transfers for non-controlled medications without restriction.

For patients relocating to Delaware, the simpler route may be to establish care with a Delaware-licensed telehealth provider rather than transferring an existing prescription. This ensures continuity of monitoring and avoids the logistical delays that sometimes accompany interstate transfers. A new visit typically takes 15 to 30 minutes.

Sildenafil Safety Data

The overall adverse event profile of sildenafil is well-characterized across more than 25 years of post-marketing surveillance. The most common side effects from the key trials were headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and visual disturbances (3%) 1.

Rare but serious adverse events include priapism (erection lasting more than 4 hours, requiring emergency intervention), non-arteritic anterior ischemic optic neuropathy (NAION), and sudden sensorineural hearing loss. The FDA issued an updated safety communication in 2007 regarding NAION risk 15. The absolute incidence of NAION with sildenafil use remains uncertain, but a 2014 meta-analysis in the British Journal of Ophthalmology estimated a relative risk of 2.07 (95% CI 1.11 to 3.87) 16.

Cardiovascular safety is reassuring for appropriately selected patients. A 2018 systematic review in the Journal of the American Heart Association (14 RCTs, N=2,387) found no increased risk of myocardial infarction, stroke, or cardiovascular death with PDE5 inhibitor use 17.

Timeline from Consultation to Medication

The typical Delaware timeline looks like this. Day one: complete an online intake or schedule a telehealth visit. Day one or two: synchronous evaluation with a licensed provider, prescription sent electronically. Day two or three: pick up at a local pharmacy, or two to five business days if ordering through a mail-order or 503A compounding pharmacy. Total elapsed time from first click to medication in hand is usually 2 to 5 days for standard generic tablets and 5 to 10 days for compounded formulations.

Patients using HealthRX's telehealth platform in Delaware can expect prescription routing within 24 hours of their completed visit, with pharmacy fulfillment depending on the dispensing pharmacy's processing speed.